Literature DB >> 15958846

Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy.

Peter A Sklar, Henry Masur, Jessica R Grubb, Jocelyn Voell, James Witek, Akira Ono, Eric O Freed, Frank Maldarelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15958846     DOI： 10.1097/01.aids.0000174461.31794.50

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

Review 1.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

2.  Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

Authors:  Nicholas T Funderburg; Ying Jiang; Sara M Debanne; Norma Storer; Danielle Labbato; Brian Clagett; Janet Robinson; Michael M Lederman; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2013-11-18       Impact factor: 9.079

3.  High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.

Authors:  Anuradha Ganesan; Nancy Crum-Cianflone; Jeanette Higgins; Jing Qin; Catherine Rehm; Julia Metcalf; Carolyn Brandt; Jean Vita; Catherine F Decker; Peter Sklar; Mary Bavaro; Sybil Tasker; Dean Follmann; Frank Maldarelli
Journal:  J Infect Dis       Date:  2011-02-15       Impact factor: 5.226

4.  Attenuation of immune activation in an open-label clinical trial for HIV-AIDS using a polyherbal formulation.

Authors:  Mangaiarkarasi Asokan; Vijaya Sachidanandam; Kadappa Shivappa Satish; Udaykumar Ranga
Journal:  Virusdisease       Date:  2014-05-21

5.  Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study.

Authors:  María Jose Míguez; John E Lewis; Vaughn E Bryant; Rhonda Rosenberg; Ximena Burbano; Joel Fishman; Deshratn Asthana; Rui Duan; Nair Madhavan; Robert M Malow
Journal:  J Int AIDS Soc       Date:  2010-07-13       Impact factor: 5.396

Review 6.  Lipids and membrane microdomains in HIV-1 replication.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  Virus Res       Date:  2009-04-19       Impact factor: 3.303

7.  Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study.

Authors:  Livio Azzoni; Andrea S Foulkes; Cynthia Firnhaber; Xiangfan Yin; Nigel J Crowther; Deborah Glencross; Denise Lawrie; Wendy Stevens; Emmanouil Papasavvas; Ian Sanne; Luis J Montaner
Journal:  J Int AIDS Soc       Date:  2011-07-29       Impact factor: 5.396

8.  Current use of statins reduces risk of HIV rebound on suppressive HAART.

Authors:  Henning Drechsler; Colby Ayers; James Cutrell; Naim Maalouf; Pablo Tebas; Roger Bedimo
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

9.  The Role of Lipids in Retrovirus Replication.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  Viruses       Date:  2010-05-01       Impact factor: 5.048

10.  Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial.

Authors:  Carlos J Montoya; Fabian Jaimes; Edwin A Higuita; Sandra Convers-Páez; Santiago Estrada; Francisco Gutierrez; Pedro Amariles; Newar Giraldo; Cristina Peñaloza; Maria T Rugeles
Journal:  Trials       Date:  2009-06-18       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.